[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001278011A1 - Bstp-ecg1 protein and related reagents and methods of use thereof - Google Patents

Bstp-ecg1 protein and related reagents and methods of use thereof

Info

Publication number
AU2001278011A1
AU2001278011A1 AU2001278011A AU7801101A AU2001278011A1 AU 2001278011 A1 AU2001278011 A1 AU 2001278011A1 AU 2001278011 A AU2001278011 A AU 2001278011A AU 7801101 A AU7801101 A AU 7801101A AU 2001278011 A1 AU2001278011 A1 AU 2001278011A1
Authority
AU
Australia
Prior art keywords
ecg1
bstp
protein
methods
related reagents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278011A
Inventor
David Botstein
Patrick O Brown
Chuck Perou
Douglas Ross
Rob Seitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Applied Genomics Inc
Original Assignee
Leland Stanford Junior University
Applied Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University, Applied Genomics Inc filed Critical Leland Stanford Junior University
Publication of AU2001278011A1 publication Critical patent/AU2001278011A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001278011A 2000-07-26 2001-07-26 Bstp-ecg1 protein and related reagents and methods of use thereof Abandoned AU2001278011A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22096700P 2000-07-26 2000-07-26
US60/220,967 2000-07-26
US25166900P 2000-12-06 2000-12-06
US60/251,669 2000-12-06
PCT/US2001/023439 WO2002008260A2 (en) 2000-07-26 2001-07-26 Bstp-ecg1 protein and related reagents and methods of use thereof

Publications (1)

Publication Number Publication Date
AU2001278011A1 true AU2001278011A1 (en) 2002-02-05

Family

ID=26915369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278011A Abandoned AU2001278011A1 (en) 2000-07-26 2001-07-26 Bstp-ecg1 protein and related reagents and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2001278011A1 (en)
WO (1) WO2002008260A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799555B1 (en) 2002-03-13 2017-02-22 Genomic Health, Inc. Gene expression profiling in biopsied tumor tissues
CA2506066A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
US20040231909A1 (en) 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
EP1597391B1 (en) 2003-02-20 2008-10-29 Genomic Health, Inc. Use of intronic rna to measure gene expression
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
JP4680898B2 (en) 2003-06-24 2011-05-11 ジェノミック ヘルス， インコーポレイテッド Predicting the likelihood of cancer recurrence
ES2905579T3 (en) 2003-07-10 2022-04-11 Genomic Health Inc Expression profiling algorithm and test for prognosis of breast cancer relapse
US7825235B2 (en) 2003-08-18 2010-11-02 Isis Pharmaceuticals, Inc. Modulation of diacylglycerol acyltransferase 2 expression
WO2005064019A2 (en) 2003-12-23 2005-07-14 Genomic Health, Inc. Universal amplification of fragmented rna
ES2550614T3 (en) 2004-04-09 2015-11-11 Genomic Health, Inc. Gene expression markers to predict the response to chemotherapy
US7587279B2 (en) 2004-07-06 2009-09-08 Genomic Health Method for quantitative PCR data analysis system (QDAS)
ATE550440T1 (en) 2004-11-05 2012-04-15 Genomic Health Inc MOLECULAR INDICATORS FOR BREAST CANCER PROGNOSIS AND PREDICTION OF TREATMENT RESPONSE
AU2005304824B2 (en) 2004-11-05 2011-12-22 Genomic Health, Inc. Predicting response to chemotherapy using gene expression markers
EP2016247A4 (en) 2006-05-08 2013-07-17 Canimex Inc Brake device with integrated anti-theft mechanism for garage doors and the like, and door assembly including the same
US8003620B2 (en) 2006-08-04 2011-08-23 Isis Pharmaceuticals, Inc. Compositions and their uses directed to diacylglycerol acyltransferase 1
EP3320094B1 (en) 2015-07-10 2022-04-13 Ionis Pharmaceuticals, Inc. Modulators of diacyglycerol acyltransferase 2 (dgat2)
CN110489660B (en) * 2019-07-22 2020-12-18 武汉大学 User economic condition portrait method of social media public data

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE335199T1 (en) * 1998-02-25 2006-08-15 Us Health METHOD AND DEVICE FOR CREATING AN ARRAY FOR FAST MOLECULAR PROFILE IDENTIFICATIONS
DE19813835A1 (en) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy
NZ510464A (en) * 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof

Also Published As

Publication number Publication date
WO2002008260A9 (en) 2003-03-20
WO2002008260A2 (en) 2002-01-31
WO2002008260A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
HK1053673A1 (en) Methods of protein destabilization and uses thereof
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
AU2001296466A1 (en) Kini-3 motor protein and methods for its use
AU2001281002A1 (en) Motor proteins and methods for their use
AU2001274566A1 (en) Novel protein and dna thereof
AU2001266961A1 (en) Novel motor proteins and methods for their use
AU2001283207A1 (en) Novel motor proteins and methods for their use
AU2001292468A1 (en) Methods and means of rna analysis
AU2001284651A1 (en) Secreted proteins and methods of using same
AU2001280993A1 (en) Tissue-associated proteins and their uses
AU5634400A (en) Shank proteins and methods of use thereof
AU2001259240A1 (en) Novel stmst protein and nucleic acid mocecules and uses therefor
AU2001277200A1 (en) Bstp-cad protein and related reagents and methods of use thereof
AU2001264726A1 (en) Novel motor proteins and methods for their use
AU2001297707A1 (en) Motor proteins and methods for their use
AU2002239235A1 (en) Gpcr-like protein and nucleic acids encoding same
AU2002248697A1 (en) Novel rgs9 protein binding interactions and methods of use thereof
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor
AU2002240921A1 (en) Medane genes and proteins